Clients in the News
November 22, 2011
Scientia’s Harry Glorikian quoted in Genetics Engineering News, “Product and Service Firms Challenged by Uncertain NIH Funding, Polarization of Sequencing”
November 21, 2011
Mass High Tech: Life science startup PhotOral Inc. signs exclusive license with The Forsyth Institute for blue-light gum disease treatment device.
October 1, 2011
Business Outlook Magazine India Quotes Scientia Advisors on Anti-Aging Industry
September 07, 2011
Stock News Now Wire interviews Harry Glorikian on personalized medicine and the impact of sequencing on clinical decisions and therapeutics choiceshttp://www.scientiaadv.com/snn-wire-interviews-harry-glorikian-on-personalized-medicine-and-impact-of-sequencing.php
June 16, 2011
BioPharm Insight quotes Scientia Advisors’ Jonathan Pan
Abigail Moss and Kimberly Ha
June 06, 2011
CNBC Quotes Bob Jones in article on “Top-Selling Superfoods“
April 22, 2011
Boston Business Journal Quotes Patrick Terry in Federal budget cuts have small biotechs nervous
April 12, 2011
The Boston Globe Quotes Scientia Advisors in “Takeda’s Millennium buy a boost for both“
March 28, 2011
The Health Care Blog Publishes Scientia’s post on “The Promise of Stem Cell Research“
March 21, 2011
Boston Globe Quotes Harry Glorikian in “Patients Activists More Involved in Health Care“
March 02, 2011
BioPharm Insight Quotes Jonathan Pan, Scientia Advisors, in articles on NPS’ Gattex and KV Pharmaceutical’s Makena
February 16, 2011
Boston Globe quotes Harry Glorikian in article on “Genzyme agrees to $20.1b sale to drug giant – Far-reaching deal for Mass. biotech”
February 03, 2011
European Biotechnology News Quotes Harry Glorikian in “Personalised Medicine: A new force for new biopharma deals“
January 24, 2011
Scientia Advisors’ Market Numbers Referenced in GEN’S article “PerkinElmer Steps into DNA Sequencing Market”
January 21, 2011
Boston Business Journal Quotes Patrick Terry in Tougher FDA giving local biotechs headaches
January 14, 2011
Pharma/diagnostics partnerships becoming a “must have,” Harry Glorikian of Scientia Advisors tells Diagnostics Testing and Technology Report
January 07, 2011
Arshad Ahmed quoted in “Healthcare at Home” by The Deal
January 06, 2011
Predictions for 2011: Troublesome transition year for pharma-biotech players
December 08, 2010
GenomeWeb Quotes Patrick Terry in Payors Weigh in on Interface of Personalized Medicine and Comparative Effectiveness Research
November 17, 2010
EBD Group quotes Harry Glorikian in Stratified medicine moves out of R&D into business development
November 16, 2010
BioWorld Today Quotes Harry Glorikian in ‘Stratified Medicine’ Shatters Bio-Pharma Partnering Model
John Brosky
October 28, 2010
Bloomberg Businessweek Quotes Scientia Advisors’ Bob Jones in What’s Next in Superfoods
David Sax
October 28, 2010
Xconomy Quotes Scientia DNA Sequencing Market Numbers in PacBio IPO, Not Exactly the Netscape Moment of 2010, But a Win for Genomics
Luke Timmerman
October 27, 2010
Harry Glorikian Comments on the Cambridge Area’s Attractiveness to Pharmaceutical Companies in a Boston Globe Article on Novartis doubles plan for Cambridge
Casey Ross and Robert Weisman
October 14, 2010
MassDevice Quotes Harry Glorikian in Article Your genome will be part of your electronic medical record
MassDevice staff
October 01, 2010
Mass High Tech Quotes Harry Glorikian in Article on “Mass. drug companies drawing Japanese interest”
Julie M. Donnelly
September 11, 2010
Boston Globe quotes Harry Glorikian in article on “Genzyme to slash 1,000 positions – Worldwide cuts as firm fends off buyer”
Robert Weisman and Steven Syre, The Boston Globe
August 30, 2010
Boston Globe quotes Harry Glorikian in article on “Drug giant bids $18.5b for Genzyme”
Robert Weisman, The Boston Globe
August 18, 2010
International Business Times quotes Scientia Advisors’ DNA sequencing market numbers in “News galore at gene sequencing firms”
August 17, 2010
Reuters Quotes Scientia Advisors’ DNA Sequencing Market Numbers in Story About Pacific Biosciences filing for IPO
Liana B. Baker, Reuters
August 03, 2010
The Boston Globe quotes Harry Glorikian in “Genzyme’s in play, and it’s all about price”
Robert Weisman, The Boston Globe
July 30, 2010
Pharmalot: “Generic Lovenox & An FDA Precedent: Scientia’s Jonathan Pan Explains”
Ed Silverman, Pharmalot
July 15, 2010
Businessweek quotes Harry Glorikian in “The Race for Diagnostic Tests for Alzheimer’s”
Elizabeth Lopatto and Kanoko Matsuyama, Bloomberg Businessweek
July 09, 2010
Businessweek quotes Harry Glorikian in “GE, Bayer Loom Over Avid’s Lead in Creating Alzheimer’s Test”
Elizabeth Lopatto and Kanoko Matsuyama, Bloomberg Businessweek
July 06, 2010
GenomeWeb quotes Harry Glorikian in “M&A May Be on the Rebound in MDx, ‘Omics Tools”
Tony Fong, GenomeWeb
June 11, 2010
Scientia Partner Gives Interview to FOX Business News on Regenerative Medicine
June 04, 2010
New Statesman quotes Harry Glorikian in “Pharma firms are increasingly seeking to outsource manufacturing”
New Statesman
June 02, 2010
Outsourcing-Pharma quotes Harry Glorikian in “Large pharma to boost CMOs’ biologics business; report”
Nick Taylor, Outsourcing-Pharma
June 02, 2010
The Boston Globe quotes Scientia’s partner in Covidien buys device maker for $2.6b – Deal for ev3 offers entry into lucrative vascular market
Robert Weisman, The Boston Globe
May 18, 2010
The triple play- With three blockbuster drugs, the future seems bright for biotech Biogen Idec
Robert Weisman, The Boston Globe
May 14, 2010
Drug Wars – How GSK is trying to reinvent itself as a pharmaceutical giant by using the acquisition model rather than relying on its R&D pipeline
Frank Vinluan, Triangle Business Journal
April 30, 2010
Boston Business Journal comments on Scientia’s growth in “Biotech cos. embrace a hiring culture”
Julie M. Donnelly, Boston Business Journal
April 27, 2010
Charles River to buy WuXi for $1.6b – Deal improves position in drug, biotech market
Robert Weisman, The Boston Globe
April 22, 2010
Regenerative Medicine to Be a $20 Billion Industry by 2025
Brendon Nafziger, DOTmed
April 12, 2010
Adoption of Telehealth Slowed By Payer Reimbursement Limits
Open Minds
March 30, 2010
Remote Health Management Market to Double in Next Five Years
Brendon Nafziger, DOTmed
March 26, 2010
RHM market to see big growth, as well as adoption roadblocks
Amanda Pedersen, Medical Device Daily
March 22, 2010
Medipacs’ Polymer Technology Positions Firm for Long-Term Growth
Daniel Pearson, San Diego Business Journal
March 18, 2010
GenomeWeb quotes Harry Glorikian in “Healthlinx Launches OvPlex in UK, Heating Up Race to Get Ovarian Cancer Dx to Market”
Tony Fong, GenomeWeb
March 17, 2010
Advances in Personalized Medicine
The Editors, Bio*IT World
March 08, 2010
Money Health: Go East, Young Man?
Brendon Nafziger, DOTmed
March 01, 2010
NUTRA Solutions quotes Bob Jones in “NUTRITIONAL Product Opportunities”
Claudia Dziuk O’Donnell, NUTRA Solutions
February 26, 2010
Growth Spurts Ahead for China’s IVD, HIT Markets
Brendon Nafziger, DOTmed
February 12, 2010
Report: China’s healthcare spending to reach $600B by 2015
Omar Ford, Medical Device Daily Staff Writer
January 15, 2010
Drug Companies Likely To Stay Cautious On Large Biotech Deals - Dow Jonesarticle
Tom Gyrta, Dow Jones
January 15, 2010
Biotech IPOs on the rise in Mass
Julie M. Donnelly, Mass High Tech
January 05, 2010
Government Funding, Technological Advances Transform Healthcare
Barbara DePompa, Federal Computer Week
December 24, 2009
HIT Fastest Growing Segment of Global Health Care Market
Advance for Health Information Executives
December 02, 2009
State of the Industry Review
Rebecca Wright, Nutraceuticals World
December 01, 2009
H1N1 Boosts Development in Pharma Sector – Many Factors, Chief Among Them a Potential Pandemic, Are Fueling Vaccine Resurgence
Rod Raynovich, Genetic Engineering & Biotechnology News
November 11, 2009
HIT to Become a $60 B Market by 2013
Brendon Nafziger, Writer, DOTmed
November 11, 2009
Boom Times For Health IT Sector: The healthcare IT marketplace is growing by 11% annually, which will likely continue through 2013, says a study from Scientia Advisors
Mitch Wagner, Information Week
November 10, 2009
Healthcare Finance News–Consultant: Healthcare IT market to grow 11 percent per year through 2013
Bernie Monegain, Contributing Editor, Healthcare Finance News
November 09, 2009
Cosmetics Design–Massive growth in cosmeceuticals leads to ingredients shortage
Simon Pitman, Cosmetics Design
November 06, 2009
The London Independent–As populations age, demand for ‘cosmeceuticals’ expected to rise
The London Independent
November 05, 2009
Medical Device Daily–Scientia Study shows selfcare growing for delivery devices
Omar Ford, Staff Writer, Medical Device Daily
November 02, 2009
Featured Article: Pharmacogenomics
Jeffrey M. Perkel, Biocompare
October 23, 2009
Confusing Choices for Doctors and Type 2 Diabetes Patients:
Drugs in development and on the market are dogged by serious side effects.
Patricia F. Dimond Ph.D., Genetic Engineering & Biotechnology News
October 22, 2009
Scientia comments on vaccine industry for CBS Evening News
Jim Axelrod, CBS News
October 21, 2009
Fierce Vaccines–Swine flu hands vax industry $7B windfall
John Carroll, Fierce Vaccines
October 21, 2009
Boston Globe–For drug makers, a shot in the arm: The quest for an H1N1 vaccine has been good business for some firms
Robert Weisman, Boston Globe
September 22, 2009
GenomeWeb–CombiMatrix Hires Baird to Provide ‘Strategic Advice’ in Buyers’ Market
GenomeWeb Staff, GenomeWeb
September 21, 2009
GenomeWeb: ProteoMonitor–Recent Deals Suggest Proteomics, Life-Science Markets May be Poised to Renew M&A Activity
ProteoMonitor Staff, GenomeWeb
September 16, 2009
GenomeWeb: ProteoMonitor–Tale of Danaher: From Crippled Real Estate Investment Trust to Mass Spec Top Banana
Tony Fong, GenomeWeb
September 01, 2009
Biomedical Business & Technology–Harry Glorikian, Consulting firm founder, Helping mold the future for med-tech firms
Jim Stommen, Contributing Editor, Biomedical Business & Technology
August 31, 2009
LA Times–Medical testing in your home: Forget the office visit. Home-health exams can save time and money, and give patients some control.
Kathleen Kelleher, LA Times
August 22, 2009
Medical Device Daily–Growing neurostimulation sector is opportunity for device makers
Lynn Yoffee, Medical Device Daily
August 19, 2009
The Marker – Who will gain from the chronic problems of the US? (trans.)
Paz Vaysman, The Marker
August 14, 2009
Mass High Tech–Life sciences startups launching despite recession
Julie M. Donnelly, Mass High Tech
July 28, 2009
Medical Device Daily–Consulting firm head sees opportunity in reform effort
Jim Stommen, Medical Device Daily Contributing Writer
July 27, 2009
Agilent Plans to Buy Varian for $1.5 Billion to Expand Footprint in Life Sciences
Tony Fong, Genome Web
June 25, 2009
Medical Device Daily–Scientia says opportunities abound in peripheral sector
Jim Stommen, Executive Editor
June 24, 2009
Xconomy – Biogen and Fellow Boston-Area Biotechs Ready for Biogenerics
Ryan McBride, Xconomy
May 26, 2009
BioWorld – Patents: Lifeblood of Biotech or a Cancer to Innovation?
Anette Breindl, BioWorld: Financial Watch
May 08, 2009
Science interviews Harry Glorikian in
Jeffrey M. Perkel, Science
April 01, 2009
MDx will drive personalized medicine
Vicki Glaser, Genetic Engineering & Biotechnology News
March 10, 2009
Scientia, a Life Sciences Management Consulting Firm, Provides Answers, Not Questions
Wade Roush, Xconomy
March 06, 2009
The Wall Street Journal uses Scientia Advisors’ medical device market growth estimates
Alicia Mundy, The Wall Street Journal
February 02, 2009
When drugs get personal
Med Ad News
January 14, 2009
Expert: Diagnostics could increase drugmakers’ revenue
BIO SmartBrief
January 13, 2009
New Personalized Medicine Model Proposed
United Press International
January 05, 2009
Principal Bob Jones interviewed on Public Radio International’s
Lisa Mullins, PRI’s The World
January 05, 2009
Bob Jones of Scientia Advisors Discusses the Growth of the Functional Foods Market
Dan Mitchell, BNET Food